Increased FDG uptake in breast cancer is associated with prognostic factors

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake

(2011) L. K. Dunnwald et al.   CLINICAL CANCER RESEARCH

Staging of Breast Cancer with Ultrasound

(2011) Wei Tse Yang   SEMINARS IN ULTRASOUND CT AND MRI

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients

(2010) Marieke E. Straver et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

(2010) Pierre Heudel et al.   International Journal of Clinical Oncology

18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis

(2010) J. R. Osborne et al.   JOURNAL OF NUCLEAR MEDICINE

18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer

(2009) Joan Duch et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis

(2009) Colleen M Costelloe et al.   LANCET ONCOLOGY

Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer

(2008) S. Ueda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Is There a Role for Positron Emission Tomography in Breast Cancer Staging?

(2008) Nicole C. Hodgson et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters

(2007) Sandip Basu et al.   CANCER